[EN] MK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE MK2 ET LEURS UTILISATIONS
申请人:XINTHERA INC
公开号:WO2022212489A1
公开(公告)日:2022-10-06
Described herein are MK2 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of autoimmune disorders, chronic inflammatory disorders, acute inflammatory disorders, auto-inflammatory disorders, fibrotic disorders, metabolic disorders, neoplastic disorders, and cardiovascular or cerebrovascular disorders.